Shade Matching of Omnichroma (One Shade Universal Composite) Versus a Microhybrid Composite in Class V Restorations.
Launched by CAIRO UNIVERSITY · Oct 14, 2019
Trial Information
Current as of May 23, 2025
Unknown status
Keywords
ClinConnect Summary
Background and rationale:
Research question:
In class V restorations will there be a difference in shade matching between Omnichroma (one shade) universal composite and a microhybrid (multiple shade) universal composite?
Statement of the problem:
The shade selection is carried out subjectively with a visual shade guide and generally under inadequate light conditions, which can lead to errors in color perception. The presence of discrepancies between the classic shade guides and the actual shade of composite makes that task more difficult. Not only that, but there was also mismatch betwe...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • 1. Patients with carious class V lesions
- • 2. Non-carious cervical abfraction lesions
- • 3. Young adult Males or female
- • 4. Good oral hygiene
- • 5. Co-operative patients approving to participate in the study
- Exclusion Criteria:
- • 1. Patients with a compromised medical history.
- • 2. Severe or active periodontal disease
- • 3. Severe medical complications
- • 4. Erosive lesions
- • 5. Lack of compliance and rampant caries
About Cairo University
Cairo University, a premier institution in Egypt, is dedicated to advancing medical research and education through innovative clinical trials. With a strong emphasis on improving healthcare outcomes, the university collaborates with various stakeholders to conduct rigorous scientific studies that address critical health challenges. Leveraging its extensive resources and expert faculty, Cairo University aims to contribute valuable insights to the medical community and enhance patient care both locally and globally. Through its commitment to ethical research practices and excellence, the university plays a pivotal role in shaping the future of healthcare in the region.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Cairo, , Egypt
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials